Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies

Malka Epel, Irit Carmi, Sharon Soueid-Baumgarten, SangKon Oh, Tapan Bera, Ira Pastan, Jay Berzofsky, Yoram Reiter

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

MHC class I molecules are important components of immune surveillance. There are no available methods to directly visualize and determine the quantity and distribution of MHC/peptide complexes on individual cells or to detect such complexes on antigen-presenting cells in tissues. MHC-restricted relcombinant antibodies with the same specificity of T cell receptors (TCR) may become a valuable tool to address these questions. They may also serve as valuable targeting molecules that mimic the specificity of cytotoxic T cells. We isolated by phage display a panel of human recombinant Fab antibodies with peptide-specific, MHC-restricted TCR-like reactivity directed toward HLA-A2-restricted T cell epitopes derived from a novel antigen termed TCRγ alternative reading frame protein (TARP) which is expressed on prostate and breast cancer cells. We have characterized one of these recombinant antibodies and demonstrated its capacity to directly detect specific HLA-A2/TARP T cell epitopes on antigen-presenting cells that have complexes formed by naturally occurring active intracellular processing of the antigen, as well as on the surface of tumor cells. Moreover, by genetic fusion we armed the TCR-like antibody with a potent toxin and demonstrated that it can serve as targeting moiety killing tumor cells in a peptide-specific, MHC-restricted manner similar to cytotoxic T lymphocytes.

Original languageEnglish (US)
Pages (from-to)1706-1720
Number of pages15
JournalEuropean Journal of Immunology
Volume38
Issue number6
DOIs
StatePublished - Jun 1 2008
Externally publishedYes

Fingerprint

Reading Frames
Neoplasm Antigens
T-Cell Antigen Receptor
Prostate
T-Cell Antigen Receptor Specificity
Breast Neoplasms
HLA-A2 Antigen
T-Lymphocyte Epitopes
Antibodies
Antigen-Presenting Cells
Peptides
Proteins
Antigen Presentation
Cytotoxic T-Lymphocytes
Bacteriophages
Neoplasms
Prostatic Neoplasms

Keywords

  • Immunotoxin
  • MHC
  • Recombinant antibody
  • T-cell receptor

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies. / Epel, Malka; Carmi, Irit; Soueid-Baumgarten, Sharon; Oh, SangKon; Bera, Tapan; Pastan, Ira; Berzofsky, Jay; Reiter, Yoram.

In: European Journal of Immunology, Vol. 38, No. 6, 01.06.2008, p. 1706-1720.

Research output: Contribution to journalArticle

Epel, Malka ; Carmi, Irit ; Soueid-Baumgarten, Sharon ; Oh, SangKon ; Bera, Tapan ; Pastan, Ira ; Berzofsky, Jay ; Reiter, Yoram. / Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies. In: European Journal of Immunology. 2008 ; Vol. 38, No. 6. pp. 1706-1720.
@article{676ef178f0f542c2b265f493a31f4ad4,
title = "Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies",
abstract = "MHC class I molecules are important components of immune surveillance. There are no available methods to directly visualize and determine the quantity and distribution of MHC/peptide complexes on individual cells or to detect such complexes on antigen-presenting cells in tissues. MHC-restricted relcombinant antibodies with the same specificity of T cell receptors (TCR) may become a valuable tool to address these questions. They may also serve as valuable targeting molecules that mimic the specificity of cytotoxic T cells. We isolated by phage display a panel of human recombinant Fab antibodies with peptide-specific, MHC-restricted TCR-like reactivity directed toward HLA-A2-restricted T cell epitopes derived from a novel antigen termed TCRγ alternative reading frame protein (TARP) which is expressed on prostate and breast cancer cells. We have characterized one of these recombinant antibodies and demonstrated its capacity to directly detect specific HLA-A2/TARP T cell epitopes on antigen-presenting cells that have complexes formed by naturally occurring active intracellular processing of the antigen, as well as on the surface of tumor cells. Moreover, by genetic fusion we armed the TCR-like antibody with a potent toxin and demonstrated that it can serve as targeting moiety killing tumor cells in a peptide-specific, MHC-restricted manner similar to cytotoxic T lymphocytes.",
keywords = "Immunotoxin, MHC, Recombinant antibody, T-cell receptor",
author = "Malka Epel and Irit Carmi and Sharon Soueid-Baumgarten and SangKon Oh and Tapan Bera and Ira Pastan and Jay Berzofsky and Yoram Reiter",
year = "2008",
month = "6",
day = "1",
doi = "10.1002/eji.200737524",
language = "English (US)",
volume = "38",
pages = "1706--1720",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "6",

}

TY - JOUR

T1 - Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies

AU - Epel, Malka

AU - Carmi, Irit

AU - Soueid-Baumgarten, Sharon

AU - Oh, SangKon

AU - Bera, Tapan

AU - Pastan, Ira

AU - Berzofsky, Jay

AU - Reiter, Yoram

PY - 2008/6/1

Y1 - 2008/6/1

N2 - MHC class I molecules are important components of immune surveillance. There are no available methods to directly visualize and determine the quantity and distribution of MHC/peptide complexes on individual cells or to detect such complexes on antigen-presenting cells in tissues. MHC-restricted relcombinant antibodies with the same specificity of T cell receptors (TCR) may become a valuable tool to address these questions. They may also serve as valuable targeting molecules that mimic the specificity of cytotoxic T cells. We isolated by phage display a panel of human recombinant Fab antibodies with peptide-specific, MHC-restricted TCR-like reactivity directed toward HLA-A2-restricted T cell epitopes derived from a novel antigen termed TCRγ alternative reading frame protein (TARP) which is expressed on prostate and breast cancer cells. We have characterized one of these recombinant antibodies and demonstrated its capacity to directly detect specific HLA-A2/TARP T cell epitopes on antigen-presenting cells that have complexes formed by naturally occurring active intracellular processing of the antigen, as well as on the surface of tumor cells. Moreover, by genetic fusion we armed the TCR-like antibody with a potent toxin and demonstrated that it can serve as targeting moiety killing tumor cells in a peptide-specific, MHC-restricted manner similar to cytotoxic T lymphocytes.

AB - MHC class I molecules are important components of immune surveillance. There are no available methods to directly visualize and determine the quantity and distribution of MHC/peptide complexes on individual cells or to detect such complexes on antigen-presenting cells in tissues. MHC-restricted relcombinant antibodies with the same specificity of T cell receptors (TCR) may become a valuable tool to address these questions. They may also serve as valuable targeting molecules that mimic the specificity of cytotoxic T cells. We isolated by phage display a panel of human recombinant Fab antibodies with peptide-specific, MHC-restricted TCR-like reactivity directed toward HLA-A2-restricted T cell epitopes derived from a novel antigen termed TCRγ alternative reading frame protein (TARP) which is expressed on prostate and breast cancer cells. We have characterized one of these recombinant antibodies and demonstrated its capacity to directly detect specific HLA-A2/TARP T cell epitopes on antigen-presenting cells that have complexes formed by naturally occurring active intracellular processing of the antigen, as well as on the surface of tumor cells. Moreover, by genetic fusion we armed the TCR-like antibody with a potent toxin and demonstrated that it can serve as targeting moiety killing tumor cells in a peptide-specific, MHC-restricted manner similar to cytotoxic T lymphocytes.

KW - Immunotoxin

KW - MHC

KW - Recombinant antibody

KW - T-cell receptor

UR - http://www.scopus.com/inward/record.url?scp=49649129991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49649129991&partnerID=8YFLogxK

U2 - 10.1002/eji.200737524

DO - 10.1002/eji.200737524

M3 - Article

C2 - 18446790

AN - SCOPUS:49649129991

VL - 38

SP - 1706

EP - 1720

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 6

ER -